LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $360,000 | -11.8% | 3,151 | -2.9% | 0.01% | -13.3% |
| Q1 2019 | $408,000 | +16.6% | 3,245 | +25.8% | 0.02% | 0.0% |
| Q4 2018 | $350,000 | -23.1% | 2,579 | +55.7% | 0.02% | -6.2% |
| Q3 2018 | $455,000 | +24.0% | 1,656 | -6.6% | 0.02% | +14.3% |
| Q2 2018 | $367,000 | +31.5% | 1,773 | +5.1% | 0.01% | +27.3% |
| Q1 2018 | $279,000 | +18.2% | 1,687 | -2.0% | 0.01% | +22.2% |
| Q4 2017 | $236,000 | 0.0% | 1,722 | -0.7% | 0.01% | -10.0% |
| Q3 2017 | $236,000 | +16.8% | 1,734 | -9.4% | 0.01% | +11.1% |
| Q1 2017 | $202,000 | – | 1,913 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $6,891 | 2.63% |
| VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
| RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
| Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
| Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
| Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
| Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
| Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
| Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |